Vivo Capital
Chinese Cancer Genomics Firm Genetron Prices US IPO, Targets $175.5m
Business - Published date: .
Genetron, a Beijing-based cancer genomics firm, plans to raise up to $175.5 million by offering 13 million American dep... Read more
Chinas Oncology Drug Developer InnoCare Eyes Up To $288m In HK IPO
Business - Published date: .
Oncology therapy-focused InnoCare Pharma Limited is seeking up to HK$2.24 billion ($288 million) in an initial public o... Read more
Chinese Oncology Drug Developer Tot Biopharm Raises $75.2m In HK IPO
Business - Published date: .
Tot Biopharm, a Chinese clinical-stage biopharma firm specialized in innovative oncology drugs and therapies, has raise... Read more